Tune in for a “dynamic” webcast addressing formulation and stability of protein therapeutics with high-throughput dynamic light scattering. Live: Tuesday, Aug. 20, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Aug. 20, 2020 Register free

Wyatt Technology

Articles by Wyatt Technology

Understanding Antibody and Viral Glycoprotein Interactions

SEC-MALS Method for Characterizing mRNA

AAV CQA Analysis by SEC-MALS

AAV Quantitation and Stability Analysis

Identification of Insulin Oligomeric States

The Versatility of High Throughput Dynamic Light Scattering in Protein Characterization and Formulation Development

Trending on BioPharm International

Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development

The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA

enGene Plans Year-End BLA for Detalimogene in BCG-Unresponsive NMIBC

ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months

Sponsors Should Plan CMC Earlier When a First-in-Human Study Could Be Pivotal, Says Former FDA Reviewer Paz Vellanki